0

Brimonidine Carbamothioate Impurity

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAPB842138754
CAS842138-75-4
Molecular Weight312.19
Molecular FormulaC11H10BrN3OS

What is the molecular weight of Brimonidine Carbamothioate Impurity?

The molecular weight of Brimonidine Carbamothioate Impurity is 312.19.

What is the molecular formula of Brimonidine Carbamothioate Impurity?

The molecular formula of Brimonidine Carbamothioate Impurity is C11H10BrN3OS.

What is the CAS number of Brimonidine Carbamothioate Impurity?

The CAS number of Brimonidine Carbamothioate Impurity is 842138-75-4.

What is the chemical structure of Brimonidine Carbamothioate Impurity?

The chemical structure of Brimonidine Carbamothioate Impurity consists of 11 carbon atoms, 10 hydrogen atoms, 1 bromine atom, 3 nitrogen atoms, and 1 sulfur atom.

What is the significance of Brimonidine Carbamothioate Impurity in pharmaceuticals?

Brimonidine Carbamothioate Impurity is a potential impurity in the synthesis of the pharmaceutical drug Brimonidine, which is used to treat glaucoma and ocular hypertension.

How is Brimonidine Carbamothioate Impurity formed during the synthesis of Brimonidine?

Brimonidine Carbamothioate Impurity is formed as a byproduct or impurity during the chemical synthesis of Brimonidine.

What are some methods used to detect Brimonidine Carbamothioate Impurity in pharmaceutical formulations?

High-performance liquid chromatography (HPLC) and spectroscopic techniques like UV-Vis spectroscopy can be used to detect Brimonidine Carbamothioate Impurity in pharmaceutical formulations.

Why is it important to control the levels of Brimonidine Carbamothioate Impurity in pharmaceutical products?

Controlling the levels of Brimonidine Carbamothioate Impurity is important to ensure the safety and efficacy of the pharmaceutical product, as impurities can affect its quality and stability.

What are the potential health risks associated with the presence of Brimonidine Carbamothioate Impurity in pharmaceuticals?

The presence of Brimonidine Carbamothioate Impurity in pharmaceuticals may lead to unknown side effects, reduced effectiveness, or adverse reactions in patients.

How can the formation of Brimonidine Carbamothioate Impurity be minimized during the synthesis of Brimonidine?

The formation of Brimonidine Carbamothioate Impurity can be minimized by optimizing the synthesis process, controlling reaction conditions, and implementing proper purification techniques.

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode